Windlas Biotech Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	-	4.24	52.88	36.86	5.7	159.3
Short-Term Investments	-	154.81	256.39	217.68	1,106	151.82
Trading Asset Securities	-	2,234	1,734	1,065	648.24	231.43
Cash & Short-Term Investments	2,606	2,393	2,044	1,320	1,760	542.55
Cash Growth	22.33%	17.08%	54.86%	-25.03%	224.44%	33.42%
Accounts Receivable	-	1,669	1,363	1,169	1,108	794.13
Other Receivables	-	5.84	6.66	4.38	22.13	1.31
Receivables	-	1,674	1,369	1,173	1,130	795.44
Inventory	-	813.84	621.89	747.38	587.1	414.61
Prepaid Expenses	-	10.54	9.84	8.71	9.54	11.09
Other Current Assets	-	359.7	268.08	286.61	329.76	179.42
Total Current Assets	-	5,251	4,313	3,535	3,817	1,943
Property, Plant & Equipment	-	2,219	1,803	1,227	983.15	954.95
Long-Term Investments	-	0.5	16.38	52.44	25.61	-
Other Intangible Assets	-	67.79	44.68	14.84	8.82	4.82
Long-Term Deferred Tax Assets	-	2.83	5.72	20.25	20.35	-
Other Long-Term Assets	-	62.82	79.54	439.85	55.67	58.35
Total Assets	-	7,605	6,262	5,290	4,910	2,961
Accounts Payable	-	1,672	1,315	877.43	632.32	399.33
Accrued Expenses	-	390.73	336.36	282.13	228.55	206.6
Short-Term Debt	-	-	-	-	53.13	294.05
Current Portion of Long-Term Debt	-	271.17	1.09	3.35	3.64	10.79
Current Portion of Leases	-	32.29	15.14	15.32	5.16	5.16
Current Income Taxes Payable	-	-	-	5.91	-	-
Other Current Liabilities	-	127.87	49.81	28.28	17.06	18.26
Total Current Liabilities	-	2,494	1,718	1,212	939.86	934.19
Long-Term Debt	-	-	-	1.09	4.44	8.32
Long-Term Leases	-	22.51	20.18	30.17	-	5.17
Long-Term Deferred Tax Liabilities	-	-	-	-	-	6.83
Other Long-Term Liabilities	-	29.84	25.01	23.36	18.03	15.53
Total Liabilities	-	2,547	1,763	1,267	962.33	970.04
Common Stock	-	104.8	103.99	104.63	108.97	64.11
Additional Paid-In Capital	-	1,989	1,946	1,986	2,269	754.91
Retained Earnings	-	2,907	2,396	1,900	1,551	1,172
Comprehensive Income & Other	-	56.99	53.45	32.19	18.04	-0.03
Total Common Equity	5,341	5,058	4,499	4,023	3,948	1,991
Shareholders' Equity	5,341	5,058	4,499	4,023	3,948	1,991
Total Liabilities & Equity	-	7,605	6,262	5,290	4,910	2,961
Total Debt	312.09	325.97	36.41	49.93	66.37	323.49
Net Cash (Debt)	2,294	2,067	2,007	1,270	1,694	219.06
Net Cash Growth	18.20%	2.97%	58.08%	-25.04%	673.25%	86.75%
Net Cash Per Share	108.03	97.82	96.16	58.69	82.64	12.03
Filing Date Shares Outstanding	20.81	20.96	20.8	20.95	21.79	18.21
Total Common Shares Outstanding	20.81	20.96	20.8	20.95	21.79	18.21
Working Capital	-	2,757	2,595	2,323	2,877	1,009
Book Value Per Share	254.44	241.31	216.33	192.05	181.14	109.36
Tangible Book Value	5,270	4,990	4,455	4,008	3,939	1,986
Tangible Book Value Per Share	251.08	238.08	214.18	191.34	180.73	109.10
Land	-	313.59	313.59	313.59	215.71	215.71
Buildings	-	807.45	637.58	489.59	453.6	451.74
Machinery	-	1,970	1,639	1,005	890.46	825.48
Construction In Progress	-	32.01	57.08	138.01	75.81	0.37

Source: S&P Global Market Intelligence. Standard template. Financial Sources.